Wai Yuen Tong Medicine Holdings Limited provided consolidated earnings guidance for the six months ended September 30, 2017. The board of directors of the company announced that based on the preliminary review of the draft unaudited consolidated management accounts of the Group for the six months ended September 30, 2017, the loss attributable to owners of the parent for the six months ended September 30, 2017 is expected to be increased by approximately 20% as compared to the corresponding period in 2016. The primary reason for the expected deterioration of results performance, among other things, was mainly due to the share of the business loss of an associate of the company.